GlassScriptPhysician profile
Xinqian Chen
NPI 1467615450
$510.86
in general payments reported to CMS, 2019-2025
15 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $38.27 · 2021: $17.11 · 2022: $43.00 · 2023: $109 · 2024: $20.34 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $136.61 | 2022-2025 | Tirosint, Licart, Flector |
| Electronic Waveform Lab, INC. | $61.75 | 2019-2023 | |
| Averitas Pharma INC. | $46.85 | 2023-2025 | Qutenza |
| Allergan, INC. | $43.75 | 2019-2021 | |
| Abbvie INC. | $42.30 | 2023-2024 | Botox |
| Amgen INC. | $25.14 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $23.89 | 2025 | |
| Nalu Medical, INC. | $22.80 | 2025 | Nalu Neurostimulation System |
| Shionogi INC | $22.45 | 2019 | |
| Tonix Medicines, INC. | $15.74 | 2025 | Tonmya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.16 | 2025 | Relistor |
| Pfizer INC. | $15.10 | 2019 | |
| Biodelivery Sciences International, INC. | $14.85 | 2019 | |
| Medtronic, INC. | $12.65 | 2022 | |
| Pacira Therapeutics, INC. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xinqian Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.